WEBULL
News
NRSNW
0.2000
0.00%
0.0000
NeuroSense Therapeutics Proposes Increase in Registered Share Capital at Upcoming Shareholder Meeting
Reuters · 1d ago
NeuroSense erhält australisches Patent für PrimeC-Kombinationstherapie
Reuters · 5d ago
NeuroSense Therapeutics Secures Australian Patent for PrimeC, Expanding Global IP Protection Through 2042
Reuters · 5d ago
Weekly Report: what happened at NRSNW last week (0202-0206)?
Weekly Report · 5d ago
Weekly Report: what happened at NRSNW last week (0126-0130)?
Weekly Report · 02/02 10:04
Weekly Report: what happened at NRSNW last week (0119-0123)?
Weekly Report · 01/26 10:04
NeuroSense Therapeutics Granted U.S. Patent for Alzheimer's Disease Treatment, Extending Protection Through 2043
Reuters · 01/21 13:31
Weekly Report: what happened at NRSNW last week (0112-0116)?
Weekly Report · 01/19 10:09
Weekly Report: what happened at NRSNW last week (0105-0109)?
Weekly Report · 01/12 10:08
NeuroSense Therapeutics Appoints Alzheimer's Expert Steven Arnold to Scientific Advisory Board
Reuters · 01/08 13:45
Weekly Report: what happened at NRSNW last week (1229-0102)?
Weekly Report · 01/05 10:03
Weekly Report: what happened at NRSNW last week (1222-1226)?
Weekly Report · 12/29/2025 10:03
NEUROSENSE CONFIRMS FAVORABLE SAFETY AND TOLERABILITY OF PRIMEC IN AN ALZHEIMER'S PHASE 2 STUDY
Reuters · 12/22/2025 14:19
NeuroSense Reports PrimeC Shows Favorable Safety in Alzheimer's Phase 2 Trial
Reuters · 12/22/2025 14:18
Weekly Report: what happened at NRSNW last week (1215-1219)?
Weekly Report · 12/22/2025 10:03
Weekly Report: what happened at NRSNW last week (1208-1212)?
Weekly Report · 12/15/2025 10:08
NeuroSense Therapeutics Locks Database for Phase 2 Alzheimer's Trial with Topline Results Expected in 2026
Reuters · 12/08/2025 13:01
Weekly Report: what happened at NRSNW last week (1201-1205)?
Weekly Report · 12/08/2025 10:07
BRIEF-Neurosense Therapeutics Ltd - Resuming Regulatory Advancement In Canada For Primec In Amyotrophic Lateral Sclerosis
Reuters · 12/04/2025 13:44
Weekly Report: what happened at NRSNW last week (1124-1128)?
Weekly Report · 12/01/2025 10:04
More
Webull provides a variety of real-time NRSNW stock news. You can receive the latest news about Neurosense Therapeutics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About NRSNW
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease